Inventor · disambiguated record
Frederic Becq
Also filed as: BECQ FREDERIC
9 granted patents·1 pending application·34 citations·filing 1997–2015
81Inventor score
Top patents by PatentIndex Score
10 records- 0170US7973054B2Use of glucosidase inhibitors for therapy of mucovisidosisCENTRE NAT RECH SCIENT·Filed 2004·Granted Jul 5, 2011·7 cites·4 claims
- 0268US8492420B2Use of purine derivatives for the production of medicaments for the treatment of mucoviscidosis and diseases related to protein addressing errors in cellsBECQ FREDERIC·Filed 2007·Granted Jul 23, 2013·1 cites·16 claims
- 0363US6630482B1CFTR channel activator compounds and pharmaceutical compositions containing sameCENTRE NAT RECH SCIENT·Filed 1997·Granted Oct 7, 2003·26 cites·1 claims
- 0445US7605153B2Use of paullone derivatives for the production of medicaments for the treatment of mucoviscidosis and diseases related to protein addressing errors in cellsCENTRE NAT RECH SCIENT·Filed 2007·Granted Oct 20, 2009·0 cites·15 claims
- 0544US8242136B2Use of glucosidase inhibitors for therapy of mucovisidosisBECQ FREDERIC·Filed 2011·Granted Aug 14, 2012·0 cites·4 claims
- 0641US8252958B2Use of guanabenz and its derivatives for making drugs for treating cystic fibrosis and diseases related to a protein addressing deficiency in the cellsBECQ FREDERIC·Filed 2006·Granted Aug 28, 2012·0 cites·8 claims
- 0739US7772198B2CFTR channel modulatorsCENTRE NAT RECH SCIENT·Filed 2006·Granted Aug 10, 2010·0 cites·6 claims
- 0837US2009048260A1Use of pyrrolopyrazine derivatives for the production of medicaments for the treatment of mucoviscidosis and diseases related to protein addressing errors in cellsBECQ FREDERIC·Filed 2005·Application pending·0 cites
- 0931US7897610B2Use of benzo[c]quinolizinium derivatives for the treatment of diseases that are linked to smooth muscle cell constrictionCENTRE NAT RECH SCIENT·Filed 2003·Granted Mar 1, 2011·0 cites·13 claims
- 1023US10414768B2Compounds for treating cystic fibrosisCENTRE NAT RECH SCIENT·Filed 2015·Granted Sep 17, 2019·0 cites·6 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →